Clinical Trial Update: Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women

View source ↗

Summary

A Mayo Clinic-backed clinical trial is evaluating the addition of a genetic risk evaluation to standard breast cancer risk assessment specifically for African A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Ductal Hyperplasia
• Atypical Lobular Hyperplasia
• Breast Cancer
• Lobular Carcinoma in Situ

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia | Status: RECRUITING